Keywords: FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: γc; common gamma chain, CD132; IL; interleukin; sγc; soluble form of common gamma chain; JAK; Janus-activated kinase; STAT; signal transducer and activator of transcription; T-ALL; T-cell acute lymphocytic leukemia; B-ALL; B-cell acute lymphocytic leuke
Keywords: AC; adenocarcinomas; AdIL-32; adenoviral overexpression of IL-32; AICD; activation-induced cell death; BAVECs; bovine aortic vascular endothelial cells; BLP; bacterial lipoprotein; CML; chronic myeloid leukemia; Con A; concanavalin A; COPD; chronic obstru
Keywords: CTCL; Cutaneous T-cell lymphoma; Cutaneous tumors; Histone deacetylase inhibitor; Pruritus;
Keywords: AA; accelerated approval; ALL; acute lymphoblastic leukemia; CCyR; complete cytogenetic response; CLL; chronic lymphocytic lymphoma; CML; chronic myeloid leukemia; CRC; colorectal carcinoma; CR; complete response; CRi; complete response with incomplete bl
Keywords: Hematologic malignancy; Hypereosinophilia; Hypereosinophilic syndrome; Lymphoma; Leukemia; AICL; Angioimmunoblastic T-cell leukemia; AML; Acute myelogenous leukemia; ATLL; Adult T-cell lymphoma/leukemia; BE; Blood eosinophilia; CEL; Chronic eosinophilic l
Keywords: 4-HPR; N-(4-hydroxyphenyl)retinamide; 5â²-UTR; 5â²-untranslated region; 9-cis-RA; 9-cis retinoic acid; 9cUAB30; (2E,4E,6Z,8E)-8-(3â²,4â²-dihydro-1â²(2'H)-naphthalen-1â²-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid; Acitretin; (2E,4E,6E,8E)-9-(4-met
Keywords: 5-AC; 5-Azacytidine; CTCL; cutaneous T-cell lymphoma; DNMT; DNA methyltransferase; EGCG; (â)-Epi-gallocatechin-3-gallate; HAT; histone acetylase; HDAC; histone deacetylase; HDM; histone demethylase; HKMT; SAM-dependent histone lysine methyltransferase;
PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21
Keywords: CTCL; cutaneous T cell lymphoma; MF; mycosis fungoides; SS; Sézary syndrome; BID; benign inflammatory dermatoses; PBMC; peripheral blood mononuclear cell; IPA3; p21-activated kinase inhibitor III; IHC; immunohistochemistry; PBS; phosphate buffer saline;
Transplantation in the Treatment of Primary Cutaneous Aggressive Epidermotropic Cytotoxic CD8-Positive T-Cell Lymphoma
Keywords: Algorithms; CD8+ PCAETL; CTCL; Hematopoietic stem cell transplantation; Outcome; Response;
Highly Sensitive Virome Capture Sequencing Technique VirCapSeq-VERT Identifies Partial Noncoding Sequences but no Active Viral Infection in Cutaneous T-Cell Lymphoma
Keywords: contig; contiguous sequence; CTCL; cutaneous T-cell lymphoma; HERV; human endogenous retrovirus; HHV; human herpesvirus; HTLV-1; human T-lymphotropic virus-1; HTS; high-throughput sequencing; NCBI; National Center for Biotechnology Information; TNA; tot
SATB1 in Malignant T Cells
Keywords: CTCL; cutaneous T-cell lymphoma; MF; mycosis fungoides; miR; microRNA; siRNA; small interfering RNA; SS; Sézary syndrome; Th; T helper;
Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma
Keywords: XNBWKNWCSWBFRL-UHFFFAOYSA-N; WOGPSXAJPRAXBA-UHFFFAOYSA-N; RHUMXXCHLQENCI-UHFFFAOYSA-N; HDAC inhibitors; Squaramide; CTCL; Topical; Mycosis fungoides;
HDAC11 is a regulator of diverse immune functions
Keywords: APC; antigen presenting cell; CTCL; cutaneous T-cell lymphoma; DAMP; Damage associated molecular pattern; DC; dendritic cell; FDA; U.S. Food and Drug Administration; GVHD; graft versus host disease; HAT; histone acetyltransferase; HDAC; histone deacetylas
Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma
Keywords: CNV; copy number variation; CTCL; cutaneous T-cell lymphoma; MF; mycosis fungoides; SS; Sézary syndrome; TCR; T-cell receptor;
SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile
Keywords: CTCL; cutaneous T-cell lymphoma; LPD; lymphoproliferative disorder; LyP; lymphomatoid papulosis; MTX; methotrexate; PCALCL; primary cutaneous anaplastic large-cell lymphoma; Th; T helper;
MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma
Keywords: AUC; area under the curve; c-ALCL; cutaneous anaplastic large cell lymphoma; BID; benign inflammatory dermatosis; CTCL; cutaneous T cell lymphoma; FFPE; formalin-fixed paraffin-embedded; MF; mycosis fungoides; miRNA; microRNA; OS; overall survival; PTCL;
Dual Role of EZH2 in Cutaneous Anaplastic Large Cell Lymphoma: Promoting Tumor Cell Survival and Regulating Tumor Microenvironment
Keywords: CD30+LPD; CD30+ lymphoproliferative disease; CTCL; cutaneous T-cell lymphoma; CXCL10; C-X-C motif chemokine ligand 10; CXCR3; C-X-C motif chemokine receptor 3; EZH2; enhancer of zeste homolog; H3K27me3; histone H3 lysine 27 trimethylation; LCT; large-cell
Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects
Keywords: B16F10; murine melanoma cells; CDCl3; deuterated chloroform; CTCL; cutaneous T-cell lymphoma; DCM; dichloromethane; DFT; density functional theory; DMAP; 4-Dimethylaminopyridine; DMEM; Dulbecco's modified Eagle's media; DMF; dimethylformamide; DMSO; dimet
Complete durable remission of a fulminant primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma after autologous and allogeneic hematopoietic stem cell transplantation
Keywords: allogeneic stem-cell transplantation; cutaneous cytotoxic T-cell lymphoma; remission; CHOEP; chemotherapy with cyclophosphamide doxorubicin, etoposide, vincristine, and prednisone; CTCL; cutaneous T-cell lymphoma; HLA; human leukocyte antigen; HSCT; hemat
Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic
Keywords: cutaneous T-cell lymphoma; erythroderma; leukemic cutaneous T-cell lymphoma; prognosis; Sézary syndrome; CTCL; cutaneous T-cell lymphoma; EORTC; European Organization for Research and Treatment of Cancer; IQR; interquartile range; ISCL; International Soc
CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder
Keywords: CD8+ phenotype; cutaneous lymphoma; lymphoproliferative disorder; mycosis fungoides; prognosis; skin directed-therapies; BSA; body surface area; CTCL; cutaneous T-cell lymphoma; HL; Hodgkin lymphoma; LyP; lymphomatoid papulosis; MF; mycosis fungoides; PCA
Ontak-like human IL-2 fusion toxin
Keywords: Ontak; IL-2 fusion toxin; CTCL; CD25; Diphtheria toxin; Pichia Pastoris;
MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients
Keywords: SAMHD1; sterile alpha motif and HD domain containing protein 1; CTCL; cutaneous T-cell lymphoma; SS; Sézary syndrome; miR; microRNA; CLL; chronic lymphocytic leukemia; AGS; Aicardi-Goutierres syndrome; Cutaneous T-cell lymphoma; MicroRNA; SAMHD1; Sèza
Hematologic neoplasms: Dendritic cells vaccines in motion
Keywords: DCs; dendritic cells; TAA; tumor-associated antigens; APC; antigen presenting cells; mDCs; myeloid dendritic cells; pDCs; plasmacytoid dendritic cells; HLA; human leukocyte antigen; Ag Antigens; abs antibodies; PBMCs; peripheral blood mononuclear cells; G
FISH Panel for Leukemic CTCL
Keywords: CTCL; cutaneous T cell lymphoma; F-MF; follicular mycosis fungoides; FISH; fluorescence in situ hybridization; GCNA; gene copy number alteration; ISCL; International Society of Cutaneous Lymphoma; L-CTCL; leukemic cutaneous T-cell lymphoma; MF; mycosis fu
Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155
Keywords: CTCL; cutaneous T-cell lymphoma; MF; mycosis fungoides; NK; natural killer; PBMC; peripheral blood mononuclear cell; SS; Sézary syndrome;
BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma
Keywords: CTCL; cutaneous T-cell lymphoma; HDAC; histone deacetylase; HDACi; histone deacetylase inhibitor; IC50; half maximal inhibitory concentration; MF; mycosis fungoides; SAHA; suberoylanilide hydroxamic acid;
The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma
Keywords: CTCL; cutaneous T-cell lymphomas; mRNA; messenger RNA; siRNA; small interfering RNA; STAT3; signal transducer and activator of transcription 3;
A new protoparvovirus in human fecal samples and cutaneous T cell lymphomas (mycosis fungoides)
Keywords: Cutavirus; Protoparvovirus; Oncolytic; CTCL;
Original articleCutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction
Keywords: cutaneous T-cell lymphoma; flow cytometry; mycosis fungoides; peripheral blood analysis; Sézary syndrome; T-cell receptor-Vβ; CTCL; cutaneous T-cell lymphoma; EORTC; European Organization for Research and Treatment of Cancer; ISCL; International Society
Original ArticleTumor BiologyIndependent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma
Keywords: CN; copy number; CTCL; cutaneous T-cell lymphoma; HC; healthy control; MF; mycosis fungoides; MTAP; methylthioadenosine phosphorylase; NGS; next generation sequencing; PBMC; peripheral blood mononuclear cells; Q-PCR; quantitative reverse transcriptase in
Original ArticleTumor BiologyInactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma
Keywords: CTCL; cutaneous T-cell lymphoma; PBMC; peripheral blood mononuclear cell; SNP; single-nucleotide polymorphism; SS; Sézary syndrome; Th; T helper;
Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome
Keywords: CARD; capsase recruitment domain; CNV; copy number variation; CTCL; cutaneous T-cell lymphoma; kb; kilobase; Mb; megabase; MF; mycosis fungoides; RAG; recombination activating gene; SNV; single nucleotide variant; SS; Sézary syndrome; STAT; signal transd
An unusual case of cytotoxic peripheral T-cell lymphoma
Keywords: α/β T-cell lymphoma; CD56; CD4/CD8 double negative; cutaneous T-cell lymphoma; drug-induced; hydroxychloroquine; CD4/CD8 DN; CD4/CD8 double negative; CTCL; cutaneous T-cell lymphoma; EBER; Ebstein-Barr virus-encoded small RNAs; NK; natural killer; PCGD-
PLCG1 Gene Mutations Are Uncommon in Cutaneous T-Cell Lymphomas
Keywords: c-ALCL; cutaneous anaplastic large cell lymphoma; CTCL; cutaneous T-cell lymphoma; HRM; high-resolution melting; LyP; lymphomatoid papulosis; PLCG1; Phospholipase C Gamma 1; SS; Sézary syndrome; T-MF; transformed/tumoral mycosis fungoide;
Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities
Keywords: Pruritus; IL-31; Immunotherapy; CTCL;
Sézary syndrome without erythroderma
Keywords: chronic pruritus; erythroderma; invisible dermatosis; leukemic cutaneous T-cell lymphoma; nonerythrodermic; prognosis; Sézary cells; Sézary syndrome; CTCL; cutaneous T-cell lymphoma; EORTC; European Organization for Research and Treatment of Cancer; ISC
Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: Diagnostic implications
Keywords: T-bet; GATA-3; cutaneous lymphoma; mycosis fungoides; Sezary syndrome; anaplastic large cell lymphoma; T helper cell; ALK; anaplastic lymphoma kinase; CTCL; cutaneous T-cell lymphoma; C-ALCL; cutaneous anaplastic large cell lymphoma; H&E; hematoxylin and
T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides
Keywords: cutaneous T-cell lymphoma; molecular diagnostics; mycosis fungoides; next-generation sequencing; T-cell clonality; T-cell receptor rearrangement; CE; capillary electrophoresis; CTCL; cutaneous T-cell lymphoma; MF; mycosis fungoides; NGS; next-generation s
Large-Cell Transformation of Mycosis Fungoides Occurring at the Site of Previously Treated Cutaneous B-Cell Lymphoma
Keywords: B-cell; CTCL; Lymphoma; Mycosis fungoides;
Diagnostics in mycosis fungoides and Sezary syndrome
Keywords: CTCL; Mycosis fungoides; Sezary syndrome; Diagnostics
Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: AÂ Danish nationwide, population-based cohort study
Keywords: causes of death; cutaneous T-cell lymphoma; mortality; mycosis fungoides; parapsoriasis; subsequent cancers; CI; confidence interval; CTCL; cutaneous T-cell lymphoma; DCR; Danish Cancer Registry; ICD; International Classification of Diseases; MF; mycosis
Cutaneous nonmycotic T- and natural killer/T-cell lymphomas: Diagnostic challenges and dilemmas
Keywords: CD30+ lymphoproliferative disorder; cutaneous T-cell lymphoma; extranodal natural killer/T-cell lymphoma, nasal type; hydroa vacciniforme-like lymphoma; peripheral T-cell lymphoma; subcutaneous panniculitis-like T-cell lymphoma; ALCL; anaplastic large-c
Associate editor: P. MolenaarPosttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
Keywords: Histone deacetylases; Cardiovascular diseases; Posttranslational modifications; Histone deacetylase inhibitors; Therapeutics; CaMK; Ca2+/calmodulin-dependent protein kinase; CK2; Casein kinase 2; COPD; Chronic obstructive pulmonary disease; CTCL; Cutaneou
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Keywords: biologic and molecular markers; clinical and diagnostic challenges; cutaneous T-cell lymphoma; genetic aberrations; histopathology; mycosis fungoides; mycosis fungoides subtypes; pathogenesis; prognostic value; Sézary syndrome; skin homing features; tran
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Keywords: cutaneous T-cell lymphoma; immunomodulators; mycosis fungoides; phototherapy; prognosis; Sézary syndrome; skin-directed treatment; staging; systemic treatment; targeted therapies; topical corticosteroids; topical nitrogen mustard; topical retinoids/rexi
Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro
Keywords: ALA; 5-aminolevulinic acid; CTCL; cutaneous T-cell lymphoma; ECP; extracorporeal photopheresis; FBS; fetal bovine serum; HAL; hexaminolevulinate; GvHD; graft-versus-host disease; MOP; methoxypsoralen; MTS; (4,5.dimethylthiazol-2-yl)-5-(3-carboxymethoxyphe
Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights
Keywords: HDAC inhibitor; DNA damage response; DNA repair; Cell cycle checkpoints; Apoptosis; Rational combinations; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; APAF-1; apoptotic protease activating factor 1; ASK1; apoptosis signal-regulating ki
LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells
Keywords: PVL; Panton-Valentine leukocidin; AML; acute myeloid leukemia; Cyclin; cell cycle arrest regulatory protein; CTCL; cutaneous T-cell lymphoma; LtxA; leukotoxin; PMNs; polymorphonuclear leukocytes; FBS; fetal bovine serum; MTS; 3-(4,5-dimethylthiazol-2-yl)-